CELEX: 62015TA0725
Language: en
Date: 2018-12-14 00:00:00
Title: Case T-725/15: Judgment of the General Court of 14 December 2018 — Arysta LifeScience Netherlands v EFSA (Plant protection products — Procedure for reviewing the approval of the active substance diflubenzuron — Article 21 of Regulation (EC) No 1107/2009 — Conclusion of the EFSA review — Partial publication of that conclusion — Article 63 of Regulation No 1107/2009 — Request for confidential treatment of certain sections — Protection of commercial interests — Refusal to grant confidential treatment — Interest in bringing proceedings)

25.2.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 72/16
            
         
      Judgment of the General Court of 14 December 2018 — Arysta LifeScience Netherlands v EFSA
      (Case T-725/15) (1)
      
      ((Plant protection products - Procedure for reviewing the approval of the active substance diflubenzuron - Article 21 of Regulation (EC) No 1107/2009 - Conclusion of the EFSA review - Partial publication of that conclusion - Article 63 of Regulation No 1107/2009 - Request for confidential treatment of certain sections - Protection of commercial interests - Refusal to grant confidential treatment - Interest in bringing proceedings))
      (2019/C 72/19)
      Language of the case: English
      
         Parties
      
      
         Applicant: Arysta LifeScience Netherlands BV, formerly Chemtura Netherlands BV (Amsterdam, Netherlands) (represented by: C. Mereu and K. Van Maldegem, lawyers)
      
         Defendant: European Food Safety Authority (EFSA) (represented by: D. Detken and S. Gabbi, acting as Agents, and by R. Van der Hout and C. Wagner, lawyers)
      
         Intervener in support of the defendant: European Commission (represented initially by: F. Moro and P. Ondrůšek, and subsequently by P. Ondrůšek and G. Koleva, acting as Agents)
      
         Re:
      
      Application under Article 263 TFEU for the annulment of the decision of EFSA of 10 December 2015 relating to the publication of certain sections of the EFSA peer review on the review of the approval of the active substance diflubenzuron concerning the metabolite PCA.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Arysta LifeScience Netherlands BV to bear its own costs and to pay those incurred by the European Food Safety Authority (EFSA) in the present action and in the proceedings for interim measures;
               
            
                  3.
               
               
                  Orders the European Commission to bear its own costs.
               
            
         (1)  OJ C 68, 22.2.2016.